A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors / James L. Roerig en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 413-418 Título : A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors Tipo de documento: texto impreso Autores: James L. Roerig, Autor ; James E. Mitchell, Autor ; Martina de Zwaan, Autor Fecha de publicación: 2023 Artículo en la página: pp. 413-418 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Ingesta de energía, Comportamiento alimentario, Olanzapina, Risperidona. Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic associated weight gain, a feeding laboratory paradigm was developed. This study is a randomized, double-blind, parallel group trial comparing the tolerability and effects of a two-week exposure to olanzapine, risperidone or placebo on weight, resting energy expenditure (REE), and eating behaviors in 48 healthy human subjects. Link: ./index.php?lvl=notice_display&id=30885 [artículo] A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors [texto impreso] / James L. Roerig, Autor ; James E. Mitchell, Autor ; Martina de Zwaan, Autor . - 2023 . - pp. 413-418. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 413-418 Palabras clave: Antipsicóticos, Benzodiazepinas, Ingesta de energía, Comportamiento alimentario, Olanzapina, Risperidona. Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic associated weight gain, a feeding laboratory paradigm was developed. This study is a randomized, double-blind, parallel group trial comparing the tolerability and effects of a two-week exposure to olanzapine, risperidone or placebo on weight, resting energy expenditure (REE), and eating behaviors in 48 healthy human subjects. Link: ./index.php?lvl=notice_display&id=30885

A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels / James L. Roerig en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 21-26 Título : A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels Tipo de documento: texto impreso Autores: James L. Roerig, Autor ; Kristine J. Steffen, Autor ; James E. Mitchell, Autor Fecha de publicación: 2023 Artículo en la página: pp. 21-26 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Comportamiento alimentario, Risperidona Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic-associated weight gain, a feeding laboratory paradigm was developed that included obtaining plasma levels of the orexigenic peptide ghrelin that is associated with appetite and eating. This study is a randomized, double-blind, parallel group trial comparing the effects of a 2-week exposure to olanzapine, risperidone, or placebo on plasma ghrelin area under the plasma-time curve (AUC) in 28 healthy human subjects. Subjects were randomized to receive olanzapine, risperidone, or placebo and titrated over 4 days to 10 mg/d or 4 mg/d, respectively. Link: ./index.php?lvl=notice_display&id=30868 [artículo] A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels [texto impreso] / James L. Roerig, Autor ; Kristine J. Steffen, Autor ; James E. Mitchell, Autor . - 2023 . - pp. 21-26. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 21-26 Palabras clave: Antipsicóticos, Benzodiazepinas, Comportamiento alimentario, Risperidona Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic-associated weight gain, a feeding laboratory paradigm was developed that included obtaining plasma levels of the orexigenic peptide ghrelin that is associated with appetite and eating. This study is a randomized, double-blind, parallel group trial comparing the effects of a 2-week exposure to olanzapine, risperidone, or placebo on plasma ghrelin area under the plasma-time curve (AUC) in 28 healthy human subjects. Subjects were randomized to receive olanzapine, risperidone, or placebo and titrated over 4 days to 10 mg/d or 4 mg/d, respectively. Link: ./index.php?lvl=notice_display&id=30868

---

1 (1 - 2 / 2)